相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children
Jordan E. Roberts et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)
Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation
Paulina Liberman et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis
Ilaria Maccora et al.
RHEUMATOLOGY (2021)
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
Athimalaipet Ramanan et al.
TRIALS (2021)
Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK
Ameenat Lola Solebo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis
Minna-Maija Gronlund et al.
RHEUMATOLOGY (2020)
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
Elisabetta Miserocchi et al.
CLINICAL RHEUMATOLOGY (2020)
Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids
Jennifer E. Thorne et al.
OPHTHALMOLOGY (2020)
Success of Weekly Adalimumab in Refractory Ocular Inflammatory Disease
Jennifer Lee et al.
OPHTHALMOLOGY (2020)
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Athimalaipet Ramanan et al.
LANCET RHEUMATOLOGY (2020)
Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
Arnd Heiligenhaus et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis
Andrea Skrabl-Baumgartner et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases
Valeria Dipasquale et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
Sheila T. Angeles-Han et al.
ARTHRITIS CARE & RESEARCH (2019)
Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis
P. Bauermann et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial
Sarah Horton et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
Virginia Miraldi Utz et al.
PEDIATRIC RHEUMATOLOGY (2019)
Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis
Courtney McCracken et al.
EYE (2019)
Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study
Arnd Heiligenhaus et al.
RHEUMATOLOGY (2019)
Pediatric Uveitis in a Well-Defined Population: Improved Outcomes with Immunosuppressive Therapy
David S. Curragh et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2018)
Uveitis and Juvenile Psoriatic Arthritis or Psoriasis
Sherveen S. Salek et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis
Vanessa Cecchin et al.
JOURNAL OF RHEUMATOLOGY (2018)
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis
Colleen K. Correll et al.
CLINICAL RHEUMATOLOGY (2018)
Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis
Marc Breitbach et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis
Estefania Quesada-Masachs et al.
JOURNAL OF RHEUMATOLOGY (2017)
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Athimalaipet V. Ramanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy A Multicenter Study of Twenty-Five Patients
Vanesa Calvo-Rio et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes
Dragana Lazarevic et al.
ARCHIVES OF RHEUMATOLOGY (2017)
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis
Elisabetta Miserocchi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Outcome of tocilizumab treatment in refractory ocular inflammatory diseases
Sukhum Silpa-archa et al.
ACTA OPHTHALMOLOGICA (2016)
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
Christoph Tappeiner et al.
JOURNAL OF RHEUMATOLOGY (2016)
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
Carolina Birolo et al.
JOURNAL OF RHEUMATOLOGY (2016)
Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors
Melissa A. Lerman et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series
Edoardo Marrani et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
Christoph Tappeiner et al.
JOURNAL OF RHEUMATOLOGY (2015)
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis
Srishti Kothari et al.
OPHTHALMOLOGY (2015)
Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema
Marina Mesquida et al.
OPHTHALMOLOGY (2014)
Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis
Charalampia Papadopoulou et al.
JOURNAL OF PEDIATRICS (2013)
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach
Gabriele Simonini et al.
RHEUMATOLOGY (2013)
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: A consensus effort from the multinational interdisciplinary working group for uveitis in childhood
Arnd Heiligenhaus et al.
ARTHRITIS CARE & RESEARCH (2012)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis
Lucia Sobrin et al.
OPHTHALMOLOGY (2008)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
分享论文
